ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Checkpoint Therapeutics Inc

Checkpoint Therapeutics Inc (CKPT)

3.31
-0.15
(-4.34%)
Closed February 16 4:00PM
3.35
0.04
(1.21%)
After Hours: 6:55PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.35
Bid
3.30
Ask
3.35
Volume
732,921
3.21 Day's Range 3.39
1.38 52 Week Range 4.50
Market Cap
Previous Close
3.46
Open
3.37
Last Trade
3
@
3.31
Last Trade Time
Financial Volume
$ 2,404,274
VWAP
3.2804
Average Volume (3m)
1,418,995
Shares Outstanding
48,832,500
Dividend Yield
-
PE Ratio
-3.12
Earnings Per Share (EPS)
-1.06
Revenue
103k
Net Profit
-51.85M

About Checkpoint Therapeutics Inc

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodie... Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). It emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Checkpoint Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CKPT. The last closing price for Checkpoint Therapeutics was $3.46. Over the last year, Checkpoint Therapeutics shares have traded in a share price range of $ 1.38 to $ 4.50.

Checkpoint Therapeutics currently has 48,832,500 shares outstanding. The market capitalization of Checkpoint Therapeutics is $168.96 million. Checkpoint Therapeutics has a price to earnings ratio (PE ratio) of -3.12.

CKPT Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.16-4.55840455843.513.563.027414263.27795787CS
4003.353.862.688691423.15361578CS
12-0.14-4.011461318053.494.52.6814189953.51539275CS
261.1250.22421524662.234.52.069768653.34426559CS
521.3870.05076142131.974.51.386924542.96129446CS
156-18.35-84.562211981621.721.91.35300535.74853467CS
260-19.35-85.242290748922.753.7621.370914818.93768392CS

CKPT - Frequently Asked Questions (FAQ)

What is the current Checkpoint Therapeutics share price?
The current share price of Checkpoint Therapeutics is $ 3.35
How many Checkpoint Therapeutics shares are in issue?
Checkpoint Therapeutics has 48,832,500 shares in issue
What is the market cap of Checkpoint Therapeutics?
The market capitalisation of Checkpoint Therapeutics is USD 168.96M
What is the 1 year trading range for Checkpoint Therapeutics share price?
Checkpoint Therapeutics has traded in the range of $ 1.38 to $ 4.50 during the past year
What is the PE ratio of Checkpoint Therapeutics?
The price to earnings ratio of Checkpoint Therapeutics is -3.12
What is the cash to sales ratio of Checkpoint Therapeutics?
The cash to sales ratio of Checkpoint Therapeutics is 1.58k
What is the reporting currency for Checkpoint Therapeutics?
Checkpoint Therapeutics reports financial results in USD
What is the latest annual turnover for Checkpoint Therapeutics?
The latest annual turnover of Checkpoint Therapeutics is USD 103k
What is the latest annual profit for Checkpoint Therapeutics?
The latest annual profit of Checkpoint Therapeutics is USD -51.85M
What is the registered address of Checkpoint Therapeutics?
The registered address for Checkpoint Therapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Checkpoint Therapeutics website address?
The website address for Checkpoint Therapeutics is www.checkpointtx.com
Which industry sector does Checkpoint Therapeutics operate in?
Checkpoint Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
$ 3.08
(-56.31%)
430.77k
BLACUBellevue Life Sciences Acquisition Corporation
$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
$ 19.0001
(-49.58%)
1.03M
NEXNNexxen International Ltd
$ 10.30
(-49.16%)
164.82k
BSLKBolt Projects Holdings Inc
$ 0.6626
(-46.13%)
13.4M
CNSPCNS Pharmaceuticals Inc
$ 0.1415
(31.26%)
489.28M
MGOLMGO Global Inc
$ 0.7176
(-15.08%)
417.31M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
254.39M
INTCIntel Corporation
$ 23.60
(-2.20%)
230.26M
NVDANVIDIA Corporation
$ 138.85
(2.63%)
194.99M

CKPT Discussion

View Posts
georgie18 georgie18 2 weeks ago
CKPT...$3.86...Off my $3.17 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 673374

Wednesday, February 05, 2025 3:21:32 PM

Post#
673461
of 673502
CKPT...$3.71...Off my $3.17...🥳... PLEASE PAY CLOSE ATTENTION TO THE CHART... https://schrts.co/TCItqZvc ...There is a long term Cup forming here which will take a year or so if it completes...for a 10X to 12X return...Short term CKPT...needs to Break/Hold $4 if so we see $8 range... https://finance.yahoo.com/news/fda-approves-checkpoint-therapeutics-skin-142201452.html

georgie18

Member Level
Re: georgie18 post# 673246

Wednesday, February 05, 2025 10:18:46 AM

Post#
673374
of 673461
CKPT...$3.50...🥳...Off my $3.17 Alert...

georgie18

Member Level
Re: georgie18 post# 673236

Tuesday, February 04, 2025 11:03:23 AM

Post#
673246
of 673372
CKPT...$3.42...HOD off my $3.17 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 31459

Tuesday, February 04, 2025 10:08:02 AM

Post#
31479
of 31487
CKPT...$3.29...Bullish Psar Flip...🥳

georgie18

Member Level
Re: None

Monday, February 03, 2025 8:01:35 PM

Post#
673187
of 673235
CKPT...$3.17... 🥳... https://schrts.co/DJzbwPTt ...Closed above the 20MA with a strong Candle...40 Million Range Float...
👍️0
georgie18 georgie18 2 weeks ago
CKPT...$3.71...🥳... PLEASE PAY CLOSE ATTENTION TO THE CHART... https://schrts.co/TCItqZvc ...There is a long term Cup forming here which will take a year or so if it completes...for a 10X to 12X return...Short term CKPT...needs to Break/Hold $4 if so we see $8 range...
👍️0
vein vein 2 weeks ago
Have we hit bottom here ?? Thoughts anyone ?  
👍️0
vein vein 2 weeks ago
Thanhs Bubba
👍️0
bubbarayjr bubbarayjr 2 weeks ago
https://ir.stockpr.com/checkpointtx/sec-filings-email/content/0001104659-25-008258/tm255136-1_4seq1.html
👍️0
vein vein 2 weeks ago
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
👍️0
bubbarayjr bubbarayjr 2 weeks ago
CEO just awarded 1.5M shares so I expect to hear partnership/BO news soon
👍️0
vein vein 4 weeks ago
I guess this medication is worthless 
👍️ 1
vein vein 4 weeks ago
Ok this is painful 
👍️0
vein vein 1 month ago
This is ridiculous!
👍️0
vein vein 1 month ago
Seriously Zadie 
👍️0
Zadie420 Zadie420 1 month ago
I don't blame you for lightening up of your shares. The behavior of mgt at this stage is not what i thought is going to be. No direction or update from company after approval? You don't do this kind of crap if your company trading on stock mrkt. I am going to watch this for couplie of more days. I think our CEO has a serious issue with communication. Good luck to the company and his employees.
👍️0
vein vein 1 month ago
I may have to lighten up here . I thought the risk would be gone after approval 
👍️0
Zadie420 Zadie420 1 month ago
I know it is very frustrating. Silent from Mgt is appalling. Hanging there.
I am very surprised mgt have not pressure from HFs/institution investors.
👍️0
vein vein 1 month ago
Don't think that is 
👍️0
vein vein 1 month ago
I'm not feeling real comfortable about their execution here Zadie. I dint think there is any partner or buyout interest 
👍️0
vein vein 1 month ago
I fully agree Zadie! We need something positive here . I mean they had a delay and plenty of time to develop something. 
👍️0
Zadie420 Zadie420 1 month ago
I will be ok with $10. But that shows incompetents' of mgt. When you work on a drug, getting approval is one side of the puzzle. commercialization is another. I have not seen any communication from mgt since we have received an approval. This is not good in my opinion.
👍️0
vein vein 1 month ago
I would take 10 zadie! Thanks 
👍️0
Zadie420 Zadie420 1 month ago
Vein,
"J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion. Revenue TTM $613 million."

Note TTM revenue is $613 Mil. Now what do you think our BO should be for CKPT? We expect more revenue based on the # of patients. Even I use 1/10 of BO price of $14.6 Bil. Lets say $1.5 Bil. Then $30/share is reasonable. But you need to be a salesman.
👍️0
vein vein 1 month ago
That would be nice 
👍️0
Zadie420 Zadie420 1 month ago
I think CKPT is a good candid for BO since the mgt failed to deliver any price appreciation after FDA approval. I think even $1B BO i will be happy with it. Someone needs to wake up the mgt.
👍️0
vein vein 1 month ago
That was the biggest trade mistake iof my lifetime Zadie 
👍️0
Zadie420 Zadie420 1 month ago
Yeah. After what happened LWLG. That was a BS. The company performance delayed by another year.
👍️0
vein vein 1 month ago
I can't catch a break Zadie !! Thanks 
👍️0
Zadie420 Zadie420 1 month ago
Vein- I have no idea why this stock is behaving like this. With a minimum OS this should MC of $500M.( at least). I think Market is telling the company that they are not doing their job. In my eyes CEO is responsible for this fiasco.
👍️0
vein vein 1 month ago
Any thoughts on this one Zadie?? 
👍️0
Zadie420 Zadie420 1 month ago
Thanks.
👍️0
vein vein 1 month ago
Honestly Zadie, it was just an article I read in linkdln. It was put out by checkpoint . 
👍️0
Zadie420 Zadie420 1 month ago
What is the competition price? If you have a link to that report i greatly appreciate it. Keep in mind that CKPT got approval based on efficacy not financial cost. At the end survival is more important than the price of medicine. I am very surprised with CEO not addressing this issue.
👍️0
vein vein 1 month ago
Hey Zadie, they were supposed to be able to price it lower than the competition. But now they are saying parity at best . 
👍️0
Zadie420 Zadie420 1 month ago
Do you know what the pricing model was?
👍️0
vein vein 1 month ago
I saw an article that mentions we couldn't deliver on our lower pricing model and we are now seeking a partner ?? Whst the f!! 
👍️0
Zadie420 Zadie420 1 month ago
Yes it is as long as the mgt are silent. This is heaven for traders.
👍️0
vein vein 1 month ago
Man this is brutal 
👍️0
vein vein 1 month ago
Sure would be nice to see some green today !! 
👍️0
vein vein 1 month ago
Thanks Zadie 
👍️0
Zadie420 Zadie420 1 month ago
Check your browser. I can see it in my laptop as well as my phone.
👍️0
vein vein 1 month ago
Can't seem to find it attached Zadie . I see your reply though. 
👍️0
Zadie420 Zadie420 1 month ago
It is post # 272. You should be able to see it.
👍️0
vein vein 1 month ago
Hey swordsman, can you post that YouTube video again ?? Thank you ! 
👍️0
vein vein 1 month ago
Thanks ! 
👍️0
Zadie420 Zadie420 1 month ago
Check swordmsn post. There is a utube clip.
👍️0
vein vein 1 month ago
What clip ?? Mind sharing ?? 
👍️0
Zadie420 Zadie420 1 month ago
Thanks for that clip. Agree. Very interesting and positive.
Does anyone know if we are applying for approval in Europe and UK. Remember these two are two distinct RAs., sine UK exited EU. It appears there are same number pf patient as USA who can use this treatment. This will increase their revenue tremendously.
👍️0
theswordman theswordman 1 month ago
Well its NOT from mngmt. Has ZERO to do with buyouts or info for the flipper crowd

BUT--for the few investors or possible patients or people that have family/friend that might benefit from this treatment

This is VERY POSITIVE !!!!!!!!!!!!!!!!!!!

👍️ 1
vein vein 1 month ago
Man , we need something positive from management here ! 
👍️ 1
Zadie420 Zadie420 2 months ago
Well, the problem is we have no communication from mgt regarding the plan after approval. Are they applying to other RAs for approval? what is expected revenue based first approval and second approval and so on......

You cannot leave these crucial updates untouched and expect the MC increases. I think Mgt and BOD need a wake up calls.
👍️0
vein vein 2 months ago
We might as well not have gotten the drug approved! 
👍️0
Zadie420 Zadie420 2 months ago
Thx for your input
Does anyone knows the projected revenue. Tia
👍️0

Your Recent History

Delayed Upgrade Clock